Prevalence of opioid dependence in Scotland 2015–2020: A multi‐parameter estimation of prevalence (MPEP) study.

Background and aims: Drug‐related deaths in Scotland more than doubled between 2011 and 2020. To inform policymakers and understand drivers of this increase, we estimated the number of people with opioid dependence aged 15–64 from 2014/15 to 2019/20. Design: We fitted a Bayesian multi‐parameter esti...

Descripción completa

Detalles Bibliográficos
Publicado en:Addiction Vol. 119; pp. 1410 - 1421
Autores principales: Markoulidakis, Andreas, Hickman, Matthew, McAuley, Andrew, Barnsdale, Lee R., Welton, Nicky J., Glancy, Megan, Shivaji, Tara, Collins, Craig, Lang, Jaroslaw, de Wit, Femke, Hunt, Gordon, Wilkinson, Levin, Fraser, Rosalyn, Yeung, Alan, Horsburgh, Kirsten, Priyadarshi, Saket, Hutchinson, Sharon J., Jones, Hayley E.
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell Aug2024 Supplement 1
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=178210483&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 178210483
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09652140
        AIO
      jtl: Addiction
      issn: 09652140
      maglogo: Y
    pubinfo:
      dt: Aug2024 Supplement 1
      vid: 119
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        178210483
        176625554
        178210483
        178210483
        10.1111/add.16500
        178210483
      ppf: 1410
      ppct: 11
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Prevalence of opioid dependence in Scotland 2015–2020: A multi‐parameter estimation of prevalence (MPEP) study.
      aug:
        au:
          Markoulidakis, Andreas
          Hickman, Matthew
          McAuley, Andrew
          Barnsdale, Lee R.
          Welton, Nicky J.
          Glancy, Megan
          Shivaji, Tara
          Collins, Craig
          Lang, Jaroslaw
          de Wit, Femke
          Hunt, Gordon
          Wilkinson, Levin
          Fraser, Rosalyn
          Yeung, Alan
          Horsburgh, Kirsten
          Priyadarshi, Saket
          Hutchinson, Sharon J.
          Jones, Hayley E.
        affil: Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
      sug:
        subj:
          Substance Use Disorders Epidemiology
          Substance Use Disorders Drug Therapy
          Analgesics, Opioid Therapeutic Use
          Human
          Funding Source
          Scotland
          Male
          Female
          Adolescence
          Adult
          Middle Age
          Probability
          Hospitalization
          Prevalence
          Stakeholder Participation
          Adverse Drug Event
          Glasgow Coma Scale
          Healthy Aging
          Descriptive Statistics
          Confidence Intervals
          Adolescent: 13-18 years
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Male
          Female
      ab: Background and aims: Drug‐related deaths in Scotland more than doubled between 2011 and 2020. To inform policymakers and understand drivers of this increase, we estimated the number of people with opioid dependence aged 15–64 from 2014/15 to 2019/20. Design: We fitted a Bayesian multi‐parameter estimation of prevalence (MPEP) model, using adverse event rates to estimate prevalence of opioid dependence jointly from Opioid Agonist Therapy (OAT), opioid‐related mortality and hospital admissions data. Estimates are stratified by age group, sex and year. Setting: Scotland, 2014/15 to 2019/20. Participants: People with opioid dependence and potential to benefit from OAT, whether ever treated or not. Using data from the Scottish Public Health Drug Linkage Programme, we identified a baseline cohort of individuals who had received OAT within the last 5 years, and all opioid‐related deaths and hospital admissions (whether among or outside of this cohort). Measurements Rates of each adverse event type and (unobserved) prevalence were jointly modelled. Findings The estimated number and prevalence of people with opioid dependence in Scotland in 2019/20 was 47 100 (95% Credible Interval [CrI] 45 700 to 48 600) and 1.32% (95% CrI 1.28% to 1.37%). Of these, 61% received OAT during 2019/20. Prevalence in Greater Glasgow and Clyde was estimated as 1.77% (95% CrI 1.69% to 1.85%). There was weak evidence that overall prevalence fell slightly from 2014/15 (change −0.07%, 95% CrI ‐0.14% to 0.00%). The population of people with opioid dependence is ageing, with the estimated number of people aged 15–34 reducing by 5100 (95% CrI 3800 to 6400) and number aged 50–64 increasing by 2800 (95% CrI 2100 to 3500) between 2014/15 and 2019/20. Conclusions: The prevalence of opioid dependence in Scotland remained high but was relatively stable, with only weak evidence of a small reduction, between 2014/15 and 2019/20. Increased numbers of opioid‐related deaths can be attributed to increased risk among people with opioid dependence, rather than increasing prevalence.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N